KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Non-Current Deffered Revenue (2020 - 2025)

Historic Non-Current Deffered Revenue for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $74.1 million.

  • Ginkgo Bioworks Holdings' Non-Current Deffered Revenue fell 2962.08% to $74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.1 million, marking a year-over-year decrease of 2962.08%. This contributed to the annual value of $98.8 million for FY2024, which is 3750.36% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Non-Current Deffered Revenue of $74.1 million as of Q3 2025, which was down 2962.08% from $74.6 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Non-Current Deffered Revenue's 5-year high stood at $179.9 million during Q2 2023, with a 5-year trough of $60.4 million in Q1 2021.
  • For the 5-year period, Ginkgo Bioworks Holdings' Non-Current Deffered Revenue averaged around $133.0 million, with its median value being $156.0 million (2021).
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first surged by 18186.5% in 2022, then crashed by 5159.91% in 2025.
  • Ginkgo Bioworks Holdings' Non-Current Deffered Revenue (Quarter) stood at $156.0 million in 2021, then grew by 12.04% to $174.8 million in 2022, then dropped by 9.56% to $158.1 million in 2023, then crashed by 37.5% to $98.8 million in 2024, then fell by 25.02% to $74.1 million in 2025.
  • Its Non-Current Deffered Revenue stands at $74.1 million for Q3 2025, versus $74.6 million for Q2 2025 and $80.4 million for Q1 2025.